Skip to main content
Veterinary Medicines

Zoletil 50 125 mg - 125 mg Lyofilisaat en oplosmiddel voor oplossing voor injectie

Authorised
  • Tiletamine hydrochloride
  • Zolazepam hydrochloride

Product identification

Medicine name:
Zoletil 50 125 mg - 125 mg Lyofilisaat en oplosmiddel voor oplossing voor injectie
Zoletil 50 125 mg - 125 mg Lyophilisat et solvant pour solution injectable
Zoletil 50 125 mg - 125 mg Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung
Active substance:
  • Tiletamine hydrochloride
  • Zolazepam hydrochloride
Target species:
  • Cat
  • Dog
  • Wild animals
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Tiletamine hydrochloride
    145.40
    milligram(s)
    /
    1.00
    Vial
  • Zolazepam hydrochloride
    140.90
    milligram(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Powder and solvent for solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
    • Dog
    • Wild animals
  • Intravenous use
    • Cat
    • Dog
    • Wild animals
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX99
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Zoletil 50 125 mg - 125 mg Lyophilisate and solvent for solution for injection - Box with 10 vials with 675 mg lyophilisate and 10 vials with 5 ml solvent
  • Zoletil 50 125 mg - 125 mg Lyophilisate and solvent for solution for injection - Box with 1 vial with 675 mg lyophilisate and 1 vial with 5 ml solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V166887
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 23/03/2023
French (PDF)
Published on: 23/03/2023
German (PDF)
Published on: 23/03/2023

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 23/03/2023
French (PDF)
Published on: 23/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."